vs
Side-by-side financial comparison of GCL Global Holdings Ltd (GCL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
GCL Global Holdings Ltd is the larger business by last-quarter revenue ($98.7M vs $83.1M, roughly 1.2× PROCEPT BioRobotics Corp). GCL Global Holdings Ltd runs the higher net margin — -5.2% vs -38.1%, a 32.9% gap on every dollar of revenue.
GCL Global Holdings Ltd is a leading clean energy enterprise focusing on R&D, production and operation of photovoltaic products, energy storage systems and low-carbon energy solutions. Its main markets cover Asia, Europe, North America, serving utility, commercial and residential distributed energy users across the globe.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
GCL vs PRCT — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $98.7M | $83.1M |
| Net Profit | $-5.1M | $-31.6M |
| Gross Margin | 11.0% | 64.9% |
| Operating Margin | -6.7% | -4.1% |
| Net Margin | -5.2% | -38.1% |
| Revenue YoY | — | 20.2% |
| Net Profit YoY | — | -27.9% |
| EPS (diluted) | $-0.04 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | — | $76.4M | ||
| Q3 25 | $98.7M | $83.3M | ||
| Q2 25 | $142.1M | $79.2M | ||
| Q1 25 | — | $69.2M | ||
| Q4 24 | — | $68.2M | ||
| Q3 24 | $36.1M | $58.4M | ||
| Q2 24 | — | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | — | $-29.8M | ||
| Q3 25 | $-5.1M | $-21.4M | ||
| Q2 25 | $5.6M | $-19.6M | ||
| Q1 25 | — | $-24.7M | ||
| Q4 24 | — | $-18.9M | ||
| Q3 24 | $-1.9M | $-21.0M | ||
| Q2 24 | — | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | 11.0% | 64.8% | ||
| Q2 25 | 15.0% | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | 16.2% | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | -6.7% | -27.8% | ||
| Q2 25 | 2.3% | -28.0% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | -5.6% | -38.4% | ||
| Q2 24 | — | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | — | -39.1% | ||
| Q3 25 | -5.2% | -25.7% | ||
| Q2 25 | 3.9% | -24.7% | ||
| Q1 25 | — | -35.8% | ||
| Q4 24 | — | -27.6% | ||
| Q3 24 | -5.2% | -35.9% | ||
| Q2 24 | — | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | — | $-0.54 | ||
| Q3 25 | $-0.04 | $-0.38 | ||
| Q2 25 | $0.05 | $-0.35 | ||
| Q1 25 | — | $-0.45 | ||
| Q4 24 | — | $-0.34 | ||
| Q3 24 | — | $-0.40 | ||
| Q2 24 | — | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.6M | $245.6M |
| Total DebtLower is stronger | $52.0M | $51.7M |
| Stockholders' EquityBook value | $33.1M | $347.7M |
| Total Assets | $159.9M | $487.1M |
| Debt / EquityLower = less leverage | 1.57× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | $16.6M | $294.3M | ||
| Q2 25 | $18.2M | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | $2.7M | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | $52.0M | $51.6M | ||
| Q2 25 | $11.9M | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | — | $365.9M | ||
| Q3 25 | $33.1M | $380.3M | ||
| Q2 25 | $35.9M | $385.8M | ||
| Q1 25 | — | $389.2M | ||
| Q4 24 | — | $402.2M | ||
| Q3 24 | $15.9M | $241.2M | ||
| Q2 24 | — | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | — | $508.1M | ||
| Q3 25 | $159.9M | $511.5M | ||
| Q2 25 | $101.6M | $513.1M | ||
| Q1 25 | — | $519.4M | ||
| Q4 24 | — | $534.0M | ||
| Q3 24 | $49.6M | $374.1M | ||
| Q2 24 | — | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | 1.57× | 0.14× | ||
| Q2 25 | 0.33× | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | — |
| Free Cash FlowOCF − Capex | $-5.2M | — |
| FCF MarginFCF / Revenue | -5.3% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-10.3M | ||
| Q3 25 | $-4.8M | $-6.6M | ||
| Q2 25 | $-10.3M | $-15.0M | ||
| Q1 25 | — | $-17.0M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | $6.1M | $-18.8M | ||
| Q2 24 | — | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | $-5.2M | $-9.5M | ||
| Q2 25 | $-10.5M | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | -5.3% | -11.4% | ||
| Q2 25 | -7.4% | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | 0.4% | 3.4% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.84× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCL
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |